Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Transfusion
    September 2025
  1. HAUSDORF A, Derigs HG, Bonig H, Fleck E, et al
    Transient severe anemia triggered by parvovirus B19 infection in a patient with homozygous RhAG deficiency.
    Transfusion. 2025 Sep 25. doi: 10.1111/trf.18378.
    >> Share

  2. ALMAHMOUD K, Bauer S, Sherry C, Mancuso C, et al
    Provider uptake of the anemia protocol across different intensive care units over 5 years in urban medical center.
    Transfusion. 2025 Sep 17. doi: 10.1111/trf.18415.
    >> Share

    July 2025
  3. TORDON B, Alhomsi N, Iqbal A, Gangji A, et al
    Rare case of warm IgM autoimmune hemolytic anemia.
    Transfusion. 2025 Jul 24. doi: 10.1111/trf.18353.
    >> Share

  4. LIANG Y, Qu W, Lu J, Liang Y, et al
    Establishment and application of a new method for the detection of drug antibodies by flow cytometry.
    Transfusion. 2025;65:1335-1343.
    >> Share

    June 2025
  5. ABRAMS HR, Saifee NH, Miller WS 3rd, Cortez A, et al
    Alloimmunization as a barrier to gene therapy in sickle cell disease.
    Transfusion. 2025;65:1035-1039.
    >> Share

  6. HUSSAIN S, Linder G, Press CA, Vossough A, et al
    Hypertension and encephalopathy in a pediatric patient following red blood cell transfusion.
    Transfusion. 2025;65:1196-1202.
    >> Share

    May 2025
  7. DE BOER ECW, Mulder FVM, Neri S, Wiskerke-van Stuijvenberg M, et al
    Vesiculation as potential novel pathogenic mechanism in autoimmune hemolytic anemia.
    Transfusion. 2025 May 12. doi: 10.1111/trf.18270.
    >> Share

  8. ALKHATEB R, Mazzolini K, Prajapati VP, Harrison C, et al
    How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood.
    Transfusion. 2025;65 Suppl 1:S320-S327.
    >> Share

  9. BENJAMIN RJ, Pitman JP, Karim C, Huang S, et al
    A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patients.
    Transfusion. 2025;65:909-920.
    >> Share

  10. QIU A, Fliginger D, Feit Y, Hassan F, et al
    Estimating the prevalence of preoperative iron deficiency and its impact on red blood cell transfusion in adolescents undergoing scoliosis surgery: A pilot study.
    Transfusion. 2025;65:851-857.
    >> Share

  11. MALTA B, Cintho Ozahata M, Gomes Moura IC, Amorim L, et al
    Clinics and genetics of hyperhemolysis syndrome in patients with sickle cell disease.
    Transfusion. 2025;65:992-1000.
    >> Share

  12. HAN H, Hensch L, Lei I, Fasipe T, et al
    Outcomes on the use of hyperhemolysis prophylaxis in pediatric sickle cell disease patients with history of hyperhemolysis syndrome.
    Transfusion. 2025;65:1001-1006.
    >> Share

    April 2025
  13. OKADA H, Stewart KE, Shettar SS, Kulesus KJ, et al
    Association of antepartum anemia and red blood cell mass with racial and ethnic disparities in transfusion rates after cesarean delivery: A retrospective cohort study.
    Transfusion. 2025 Apr 25. doi: 10.1111/trf.18260.
    >> Share

  14. LOOBEEK D, Pacnerova L, Twisk J, So-Osman C, et al
    How do I analyze the role of red blood cell transfusions on clinical outcome in anemic patients? Disentangling the effect of red blood cell transfusions from pre-operative anemia on post-operative outcome.
    Transfusion. 2025 Apr 3. doi: 10.1111/trf.18224.
    >> Share

    March 2025
  15. UMINSKI K, Perelman I, Mack J, Tinmouth A, et al
    Red blood cell utilization in patients with sickle cell disease: A Canadian single-center experience.
    Transfusion. 2025;65:476-484.
    >> Share

    February 2025
  16. UMINSKI K, Perelman I, Tinmouth AT, Mack J, et al
    Use of automated isovolemic hemodilution red-cell exchange in patients with sickle cell disease: A Canadian single center experience.
    Transfusion. 2025;65:325-332.
    >> Share

  17. BRONS N, Kaspersen KA, Bay JT, Dowsett J, et al
    Iron deficiency and infection risk in Danish blood donors.
    Transfusion. 2025;65:286-296.
    >> Share

  18. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    Comparative efficacy of liberal and restrictive blood transfusion strategies in anemic patients with acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trials.
    Transfusion. 2025;65:260-266.
    >> Share

    January 2025
  19. CASTONGUAY M, Bernard L, Corriveau M, Castonguay A, et al
    Approach to autologous stem cell transplantation in a patient with severe cold agglutinin disease, a case report.
    Transfusion. 2025 Jan 28. doi: 10.1111/trf.18147.
    >> Share

  20. DEI-ADOMAKOH Y, Olayemi E, Telke S, Asamoah-Akuoko L, et al
    Impact of iron supplementation among anemic voluntary first-time blood donors: Results from the BLOODSAFE pilot trial in Ghana.
    Transfusion. 2025;65:131-139.
    >> Share

    December 2024
  21. JONES JM, Wool J, Crowe EP, Bloch EM, et al
    Longitudinal outcomes of chronically transfused adults with sickle cell disease and a history of childhood stroke.
    Transfusion. 2024;64:2260-2269.
    >> Share

  22. YURTSEVER N, Tong N, Geetha S, Nandi V, et al
    Post-exchange neutrophil count, but not post-hematocrit, predicts endogenous erythropoiesis in patients with sickle cell disease undergoing chronic red cell exchange.
    Transfusion. 2024;64:2270-2278.
    >> Share

    November 2024
  23. NICKEL RS, Margulies S, Panchapakesan K, Chorvinsky E, et al
    Adding hydroxyurea to chronic transfusion therapy for sickle cell anemia reduces transfusion burden.
    Transfusion. 2024 Nov 24. doi: 10.1111/trf.18073.
    >> Share

  24. BHASIN N, LeBlanc DM, Yates S, Eichbaum Q, et al
    Physician perspectives about the diagnosis and management of acute chest syndrome.
    Transfusion. 2024;64:2095-2103.
    >> Share

    October 2024
  25. ADKINS BD, Kaylani SZ, Nero A, Ibrahim IF, et al
    How do we manage hyperhemolysis syndrome.
    Transfusion. 2024;64:1822-1829.
    >> Share

  26. KARREGAT J, Meulenbeld A, Abubakar J, Quee FA, et al
    Iron deficiency-related symptoms in non-anemic whole blood donors.
    Transfusion. 2024;64:1920-1930.
    >> Share

    September 2024
  27. FISHER S, Chihuri S, Guglielminotti J, Li G, et al
    Racial and ethnic differences in transfusion rates in adolescent scoliosis surgery: Preoperative anemia as a mediator of disparity.
    Transfusion. 2024 Sep 20. doi: 10.1111/trf.18023.
    >> Share

  28. LEE GM, Boyle K, Batchvarova M, Delahunty M, et al
    Red cell exchange modulates neutrophil degranulation responses in sickle cell disease.
    Transfusion. 2024;64:1752-1761.
    >> Share

  29. SUN Q, Karafin MS, Garrett ME, Li Y, et al
    A genome-wide association study of alloimmunization in the TOPMed OMG-SCD cohort identifies a locus on chromosome 12.
    Transfusion. 2024;64:1772-1783.
    >> Share

    August 2024
  30. ZAKIEH A, Mercure-Corriveau N, Lanzkron S, Feng X, et al
    Chronic automated red cell exchange therapy for sickle cell disease.
    Transfusion. 2024;64:1509-1519.
    >> Share

  31. DENOON RB, Soares Ferreira Junior A, Tuttle B, Onwuemene OA, et al
    Therapeutic plasma exchange for sickle cell disease acute complications: A systematic review.
    Transfusion. 2024;64:1570-1587.
    >> Share

    July 2024
  32. BAYKARA Y, Nixon C, Pavlovich A, Akgun Y, et al
    Unpacking the utility of euvolemic automated transfusion in sickle cell disease.
    Transfusion. 2024;64:1381-1382.
    >> Share

  33. SRIVASTAVA K, Yin Q, Makuria AT, Rios M, et al
    CD59 gene: 143 haplotypes of 22,718 nucleotides length by computational phasing in 113 individuals from different ethnicities.
    Transfusion. 2024;64:1296-1305.
    >> Share

  34. SEEBER P, Trentino KM, Murray K, Lucas M, et al
    A further update on mortality and morbidity in patients with very low hemoglobin levels who decline blood transfusion.
    Transfusion. 2024;64:1198-1206.
    >> Share

  35. JALINK M, Yan MTS, Cohn CS, Eichbaum QG, et al
    Systematic review for the serological testing for cold agglutinins: The BEST collaborative study.
    Transfusion. 2024;64:1331-1349.
    >> Share

    June 2024
  36. YEE MEM, Covington ML, Zerra PE, McCoy JW, et al
    Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease.
    Transfusion. 2024;64:1109-1115.
    >> Share

  37. LINSTROM M, Musekwa E, Nell EM, de Waard L, et al
    The influence of hematological profiles on the transfusion management and mortality risk of mothers presenting to the obstetric unit of a South African tertiary medical facility.
    Transfusion. 2024;64:986-997.
    >> Share

    May 2024
  38. RAMSEY G, Barriteau CM
    Estimating the serological underrecognition of patients with weak or partial RHD variants.
    Transfusion. 2024;64:920-928.
    >> Share

  39. WERNEIWSKI K, Gehrie EA
    Development of an interactive mapping tool to estimate where resources for people living with sickle cell disease may be needed most.
    Transfusion. 2024;64:772-774.
    >> Share

  40. YEE MEM, Zerra PE, McCoy JW, Covington ML, et al
    Post-transfusion biotin-labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance.
    Transfusion. 2024;64:800-807.
    >> Share

    April 2024
  41. JAVANBAKHT A, Schneider TM, Hendrickson JE
    Red blood cell alloimmunization in patients on extracorporeal membrane oxygenation.
    Transfusion. 2024;64:761-762.
    >> Share

  42. ROGERS K, Alsawas M, Chapman J, Schlueter AJ, et al
    Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease.
    Transfusion. 2024;64:685-692.
    >> Share

  43. LEIVA-TORRES GA, Cigna M, Constanzo-Yanez J, St-Louis M, et al
    Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited.
    Transfusion. 2024;64:716-726.
    >> Share

  44. CHASE RC, Koop AH, Shaikh M, Imperial RJ, et al
    Successful treatment of severe passenger lymphocyte syndrome with efgartigimod synergy.
    Transfusion. 2024;64:755-760.
    >> Share

  45. WANG L, Rochon ER, Gingras S, Zuchelkowski BE, et al
    Functional effects of an African glucose-6-phosphate dehydrogenase (G6PD) polymorphism (Val68Met) on red blood cell hemolytic propensity and post-transfusion recovery.
    Transfusion. 2024;64:615-626.
    >> Share

    March 2024
  46. JORGENSEN CC, Michelsen C, Petersen T, Kehlet H, et al
    Preoperative hemoglobin thresholds for increased risk of "medical" complications in fast-track total hip and knee arthroplasty, a secondary analysis of a machine-learning algorithm.
    Transfusion. 2024;64:438-442.
    >> Share

  47. ISRAELYAN N, Vege S, Friedman DF, Zhang Z, et al
    RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
    Transfusion. 2024;64:526-535.
    >> Share

    February 2024
  48. CAO J, Lu S, Luo D, Pei R, et al
    Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
    Transfusion. 2024 Feb 13. doi: 10.1111/trf.17743.
    >> Share

  49. PETERMANN S, Mayer V, Carbol A, Opitz A, et al
    Compound heterozygosity induces a rare Gerbich-negative phenotype in an immunized blood donor.
    Transfusion. 2024;64:406-411.
    >> Share

  50. MO A, Wood E, Shortt J, Charlton A, et al
    Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromes.
    Transfusion. 2024;64:236-247.
    >> Share

    January 2024
  51. CIGNA M, Leiva-Torres GA, Baillargeon N, Yanez JC, et al
    Management of a patient with sickle cell disease and multiple red blood cell alloantibodies in preparation for a hematopoietic stem cell transplantation.
    Transfusion. 2024 Jan 11. doi: 10.1111/trf.17715.
    >> Share

  52. BRANCAMP R, Hughes CE, Dar A, Polic A, et al
    Homozygous SPTA1-associated hereditary pyropoikilocytosis presenting as hydrops fetalis.
    Transfusion. 2024;64:189-193.
    >> Share

  53. LIPMAN T, Bienz MN, Pendergrast J, Cserti-Gazdewich C, et al
    Unexpected difficulty in performance of a monocyte monolayer assay when using RBCs from a patient with sickle cell disease.
    Transfusion. 2024;64:4-5.
    >> Share

  54. STEVENS-HERNANDEZ CJ, Gyorffy G, Meli A, New HV, et al
    Vesiculation in irradiated and cation-leaky-stored red blood cells.
    Transfusion. 2024;64:150-161.
    >> Share

    December 2023
  55. CALJE E, Oyston C, Wang Z, Bloomfield F, et al
    The fatigue after infusion or transfusion pilot trial and feasibility study: A three-armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia.
    Transfusion. 2023 Dec 27. doi: 10.1111/trf.17621.
    >> Share

  56. MERCURE-CORRIVEAU N, Crowe EP, Vozniak S, Feng X, et al
    Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.
    Transfusion. 2023 Dec 8. doi: 10.1111/trf.17613.
    >> Share

  57. CROWE EP, Hasan R, Saifee NH, Bakhtary S, et al
    How do we perform intrauterine transfusions?
    Transfusion. 2023;63:2214-2224.
    >> Share

  58. KAYANO SS, Santana PV, Colella R, Colella MP, et al
    Lower platelet count and metastatic tumor are associated with increased risk of spontaneous bleeding in critically ill patients with cancer: An observational study.
    Transfusion. 2023;63:2311-2320.
    >> Share

    November 2023
  59. RYDEN J, Clements M, Wikman A, Hellstrom-Lindberg E, et al
    Red blood cell alloimmunization in myelodysplastic syndromes: Associations with sex, DAT-positivity, and increased transfusion needs.
    Transfusion. 2023;63:2040-2051.
    >> Share

    October 2023
  60. GOLLAMUDI J, Dasgupta SK, Thiagarajan P
    Erythrophagocytosis in autoimmune immunoglobulin A-mediated hemolysis.
    Transfusion. 2023;63:1978-1982.
    >> Share

    September 2023
  61. ABELS E, Jacobs JW, Prior D, Willets LC, et al
    Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia.
    Transfusion. 2023 Sep 14. doi: 10.1111/trf.17548.
    >> Share

    August 2023
  62. SOTOLONGO G, Poisson JL
    Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients.
    Transfusion. 2023 Aug 30. doi: 10.1111/trf.17529.
    >> Share

  63. LASOCKI S, Delahaye D, Fuks D, Savoie PH, et al
    Management of perioperative iron deficiency anemia as part of patient blood management in France: A budget impact model-based analysis based on real world data.
    Transfusion. 2023 Aug 23. doi: 10.1111/trf.17495.
    >> Share

  64. ARYA S, Xiang T, Tang GH, Pavenski K, et al
    Including the patient in patient blood management: Development and assessment of an educational animation tool.
    Transfusion. 2023;63:1488-1494.
    >> Share

    July 2023
  65. ABDELHAY A, Mahmoud AA, Ammari O, Dalbah R, et al
    Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.
    Transfusion. 2023 Jul 3. doi: 10.1111/trf.17445.
    >> Share

  66. WEBB CB, Yates SG, Sarode R, Kim J, et al
    Plasma exchange-A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction.
    Transfusion. 2023;63:1384-1390.
    >> Share

  67. HAW J, Walrond J, Jayachandran J, Dordunoo D, et al
    Sickle cell disease and the need for blood: Barriers to donation for African, Caribbean, and Black young adults in Canada.
    Transfusion. 2023;63:1324-1332.
    >> Share

    June 2023
  68. DESIMONE RA, Plimier C, Goel R, Hendrickson JE, et al
    Associations of donor, component, and recipient factors on hemoglobin increments following red blood cell transfusion in very low birth weight infants.
    Transfusion. 2023 Jun 30. doi: 10.1111/trf.17468.
    >> Share

  69. WALL E, Bolster L
    Complications of red cell exchange for anemia management in patients with transfusion-dependent thalassemia.
    Transfusion. 2023 Jun 15. doi: 10.1111/trf.17419.
    >> Share

  70. STEFFEN KM, Spinella PC, Holdsworth LM, Ford M, et al
    Factors influencing pediatric transfusion: A complex decision impacting quality of care.
    Transfusion. 2023;63:1151-1160.
    >> Share

    May 2023
  71. CARTER PW, Dunham AJ
    Modeling hemoglobin levels of patients chronically transfused with red blood cells.
    Transfusion. 2023;63:952-959.
    >> Share

  72. SHAULOV A, Rund D, Filon D, Nachmias B, et al
    Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease.
    Transfusion. 2023;63:1100-1106.
    >> Share

  73. YAZER MH, Spinella PC, Sperry J, Triulzi DJ, et al
    Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
    Transfusion. 2023;63 Suppl 3:S54-S59.
    >> Share

    April 2023
  74. GOEL R, Roubinian NH, Bembea MM
    Disentangling the causes of RBC loss and anemia in ECMO patients: Some questions answered?
    Transfusion. 2023 Apr 10. doi: 10.1111/trf.17347.
    >> Share

    March 2023
  75. JUTRAS C, Sauthier M, Tucci M, Trottier H, et al
    Prevalence and determinants of anemia at discharge in pediatric intensive care survivors.
    Transfusion. 2023 Mar 12. doi: 10.1111/trf.17309.
    >> Share

  76. COSTA V, Mercure-Corriveau N, Gourneau J, Tobian AAR, et al
    Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange.
    Transfusion. 2023;63:652-655.
    >> Share

  77. ALLISON D, Manon L, Vidanovic V, Crane J, et al
    How do we operate a large monthly red blood cell exchange program.
    Transfusion. 2023;63:450-456.
    >> Share

  78. CROWDER LA, Cable RG, Spencer BR
    Validity of donor-reported iron supplementation practices obtained at the time of donation.
    Transfusion. 2023;63:470-475.
    >> Share

  79. HAJJAJ OI, Cserti-Gazdewich C, Dumevska L, Hanna M, et al
    Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease.
    Transfusion. 2023;63:507-514.
    >> Share

    February 2023
  80. HE Y, Gao W, Li Y, Xu C, et al
    A single-center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti-M antibodies.
    Transfusion. 2023 Feb 2. doi: 10.1111/trf.17249.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016